Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma

H.M. Lokhorst; P. Sonneveld; P.W. Wijermans; M. van Marwijk Kooy; O.J.A.Th. Meuwissen; R.H.J. van Oers; R. van der Griend; A.W. Dekker

Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma

Translated title of the contribution: Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma

H.M. Lokhorst
, P. Sonneveld
, P.W. Wijermans
, M. van Marwijk Kooy
, O.J.A.Th. Meuwissen
, R.H.J. van Oers
, R. van der Griend
, A.W. Dekker

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma
Original language	Undefined/Unknown
Pages (from-to)	44-48
Number of pages	5
Journal	British Journal of Haematology
Volume	92
Publication status	Published - 1996

Cite this

Lokhorst, H. M., Sonneveld, P., Wijermans, P. W., van Marwijk Kooy, M., Meuwissen, O. J. A. T., van Oers, R. H. J., van der Griend, R., & Dekker, A. W. (1996). Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma. British Journal of Haematology, 92, 44-48.

@article{b4105468a53046a9ab613711e8e322ad,

title = "Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma",

author = "H.M. Lokhorst and P. Sonneveld and P.W. Wijermans and \{van Marwijk Kooy\}, M. and O.J.A.Th. Meuwissen and \{van Oers\}, R.H.J. and \{van der Griend\}, R. and A.W. Dekker",

note = "keypublication",

year = "1996",

language = "Undefined/Unknown",

volume = "92",

pages = "44--48",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley \& Sons Inc.",

}

TY - JOUR

T1 - Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma

AU - Lokhorst, H.M.

AU - Sonneveld, P.

AU - Wijermans, P.W.

AU - van Marwijk Kooy, M.

AU - Meuwissen, O.J.A.Th.

AU - van Oers, R.H.J.

AU - van der Griend, R.

AU - Dekker, A.W.

N1 - keypublication

PY - 1996

Y1 - 1996

M3 - Article

SN - 0007-1048

VL - 92

SP - 44

EP - 48

JO - British Journal of Haematology

JF - British Journal of Haematology

ER -